Sort
48,018 grants matching “immunotherapy”
Nutrient sensing ghrelin signaling - a novel pathogenic factor for Alzheimerâs Disease
$378,750Yuxiang Sun · Texas A&M Agrilife Research · R01 · FY2021 · AG
Immune Response to Cat: Regulatory and Effector T Cells
$378,750Judith A Woodfolk · University Of Virginia · R01 · FY2009 · AI
Novel collagen V-reactive natural Th17 cells in hypoxic pulmonary hypertension
$378,750Laura V Gonzalez Bosc · University Of New Mexico Health Scis Ctr · R56 · FY2020 · HL
Augmentation of GVL Reactivity Without GVHD
$378,750William R. Drobyski · Medical College Of Wisconsin · R01 · FY2008 · HL
Augmentation of GVL Reactivity Without GVHD
$378,750William R. Drobyski · Medical College Of Wisconsin · R01 · FY2007 · HL
Mechanisms of Immune Evasion by Ocular Tumors
$378,750Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · EY
Immune Response to Polyomavirus Infection
$378,749Parmjeet S Randhawa · University Of Pittsburgh At Pittsburgh · R56 · FY2012 · AI
Novel ways to prevent upper GT infection
$378,709Kathleen A. Kelly · University Of California Los Angeles · R01 · FY2010 · AI
Mechanisms of Disease Pathogenesis in Regulatory T cell Deficiency
$378,675Talal Amine Chatila · University Of California Los Angeles · R01 · FY2011 · AI
Role of IL21 in HIV Infection
$378,675Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2010 · AI
Epigenetic Regulation of Plasma Cell Differentiation
$378,663Jeremy M. Boss · Emory University · P01 · FY2020 · AI
Role of hybrid peptide specific T cells in diabetes
$378,650Brian T Fife · University Of Minnesota · P01 · FY2019 · AI
Stability and potency of LAP+FOXP3+Tregs as novel cell therapy for GVHD
$378,628Dat Quoc Tran · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · HL
Tumor microenvironment-dependent therapy resistance
$378,600Shahab Asgharzadeh · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Novel Mechanisms Regulating Posttransplant Humoral Alloimmunity
$378,597Ginny L Bumgardner · Ohio State University · R01 · FY2014 · AI
IMMUNOTHERAPY FOR DRUG ABUSE
$378,586University Of Arkansas Med Scis Ltl Rock · R01 · FY2000 · DA
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
$378,575Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Interleukin-2 and autoimmune disease
$378,564Abul K. Abbas · University Of California, San Francisco · R01 · FY2011 · AI
Interleukin-2 and autoimmune disease
$378,564Abul K. Abbas · University Of California, San Francisco · R01 · FY2012 · AI
Blockade of T-cell Co-Inhibitory Pathways & Immunotherapy to Prevent Ocular Herpe
$378,525Lbachir Benmohamed · University Of California-Irvine · R01 · FY2015 · EY
IMMUNOPHARMACOTHERAPY AS A TREATMENT FOR COCAINE ABUSE
$378,513Scripps Research Institute · R01 · FY2000 · DA
T cell homeostasis
$378,474Stephen C Jameson · University Of Minnesota · R01 · FY2020 · AI
Endogenous TLR1 signals prevent uncontrolled innate immunity in the colon
$378,469Randy William Depaolo · University Of Washington · R01 · FY2017 · DK
Administrative Core
$378,467James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
IMMUNOLOGICAL MONITORING AND CELLULAR PRODUCTS LABORATORY
$378,452Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2012 · CA